<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32622315</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>102312</StartPage><MedlinePgn>102312</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102312</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2020.102312</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(20)30149-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To evaluate the metabolic correlates of lifetime sport practice in ALS through brain <sup>18</sup>F-FDG-PET.</AbstractText><AbstractText Label="METHODS">131 patients completed a questionnaire about lifetime exposures, including physical activity related to sports, hobbies and occupations, and underwent brain <sup>18</sup>F-FDG-PET. Exposure to sports was expressed as MET (Metabolic Equivalent of Task). We considered only regular practice (at least 2&#xa0;h/week, for at least three months). We compared brain metabolism between two groups: subjects who did not report regular sport practice during life (N-group) and patients who did (Y-group). The resulting significant clusters were used in each group as seed regions in an interregional correlation analysis (IRCA) to evaluate the impact of lifetime sport practice on brain networks typically involved by the neurodegenerative process of ALS. Each group was compared to healthy controls (HC, n&#xa0;=&#xa0;40).</AbstractText><AbstractText Label="RESULTS">We found a significant, relative cerebellar hypermetabolism in the N-group compared to the Y-group. The metabolism of such cerebellar cluster resulted correlated to more significant and widespread metabolic changes in areas known to be affected by ALS (i.e. frontotemporal regions and corticospinal tracts) in the N-group as compared to the Y-group, despite the same level of disability as expressed by the ALS FRS-R. Such findings resulted independent of age, sex, site of onset (bulbar/spinal), presence/absence of C9ORF72 expansion, cognitive status and physical activity related to hobbies and occupations. When compared to HC, the N-group showed more widespread metabolic changes than the Y-group in cortical regions known to be relatively hypometabolic in ALS patients as compared to HC.</AbstractText><AbstractText Label="CONCLUSIONS">We hypothesize that patients of the N-group might cope better with the neurodegenerative process, since they show more widespread metabolic changes as compared to the Y-group, despite the same level of disability. Nevertheless, further studies are necessary to corroborate this hypothesis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Canosa</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza di Torino, SC Neurologia 1U, Turin, Italy. Electronic address: antonio.canosa@unito.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Ovidio</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza di Torino, SC Neurologia 1U, Turin, Italy; Neuroscience Institute of Turin (NIT), Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moglia</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza di Torino, SC Neurologia 1U, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manera</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torrieri</LastName><ForeName>Maria Claudia</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasta</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cistaro</LastName><ForeName>Angelina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy; Nuclear Medicine Advisor for the ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iazzolino</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nobili</LastName><ForeName>Flavio Mariano</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy; Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casale</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza di Torino, SC Neurologia 1U, Turin, Italy; Neuroscience Institute of Turin (NIT), Turin, Italy; Institute of Cognitive Sciences and Technologies, C.N.R., Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagani</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Cognitive Sciences and Technologies, C.N.R., Rome, Italy; Department of Nuclear Medicine, Karolinska Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0Z5B2CJX4D</RegistryNumber><NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019788" MajorTopicYN="N">Fluorodeoxyglucose F18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">(18)F-FDG-PET</Keyword><Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">Sport</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32622315</ArticleId><ArticleId IdType="pmc">PMC7334468</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2020.102312</ArticleId><ArticleId IdType="pii">S2213-1582(20)30149-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es M.A., Hardiman O., Chio A. Amyotrophic lateral sclerosis. Lancet Lond Engl. 2017;390(10107):2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9(11):617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastos A.F., Orsini M., Machado D. Amyotrophic lateral sclerosis: one or multiple causes? Neurol Int. 2011;3(1) doi: 10.4081/ni.2011.e4.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ni.2011.e4</ArticleId><ArticleId IdType="pmc">PMC3141115</ArticleId><ArticleId IdType="pubmed">21785676</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood C.A., McDermott C.J., Shaw P.J. Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler Off Publ World Fed Neurol Res Group Mot Neuron Dis. 2009;10(4):191&#x2013;204. doi: 10.1080/17482960802549739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802549739</ArticleId><ArticleId IdType="pubmed">19263258</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacorte E., Ferrigno L., Leoncini E., Corbo M., Boccia S., Vanacore N. Physical activity, and physical activity related to sports, leisure and occupational activity as risk factors for ALS: A systematic review. Neurosci Biobehav Rev. 2016;66:61&#x2013;79. doi: 10.1016/j.neubiorev.2016.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2016.04.007</ArticleId><ArticleId IdType="pubmed">27108217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Benzi G., Dossena M., Mutani R., Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain J Neurol. 2005;128(Pt 3):472&#x2013;476. doi: 10.1093/brain/awh373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh373</ArticleId><ArticleId IdType="pubmed">15634730</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehman E.J., Hein M.J., Baron S.L., Gersic C.M. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79(19):1970&#x2013;1974. doi: 10.1212/WNL.0b013e31826daf50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31826daf50</ArticleId><ArticleId IdType="pmc">PMC4098841</ArticleId><ArticleId IdType="pubmed">22955124</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser A.E., Rooney J.P.K., D&#x2019;Ovidio F. Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018;89(8):797&#x2013;803. doi: 10.1136/jnnp-2017-317724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317724</ArticleId><ArticleId IdType="pubmed">29685899</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Mot Neuron Disord Off Publ. World Fed Neurol Res Group Mot Neuron Dis. 2000;1(5):293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ovidio F., Rooney J.P.K., Visser A.E. Critical issues in ALS case-control studies: the case of the Euro-MOTOR study. Amyotroph Lateral Scler Front Degener. 2017;18(5&#x2013;6):411&#x2013;418. doi: 10.1080/21678421.2017.1285939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1285939</ArticleId><ArticleId IdType="pubmed">28594593</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagani M., &#xd6;berg J., De Carli F. Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis. Hum Brain Mapp. 2016;37(3):942&#x2013;953. doi: 10.1002/hbm.23078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.23078</ArticleId><ArticleId IdType="pmc">PMC6867238</ArticleId><ArticleId IdType="pubmed">26703938</ArticleId></ArticleIdList></Reference><Reference><Citation>Cistaro A., Pagani M., Montuschi A. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging. 2014;41(5):844&#x2013;852. doi: 10.1007/s00259-013-2667-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-013-2667-5</ArticleId><ArticleId IdType="pubmed">24445987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ainsworth B.E., Haskell W.L., Whitt M.C. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(9 Suppl):S498&#x2013;S504.</Citation><ArticleIdList><ArticleId IdType="pubmed">10993420</ArticleId></ArticleIdList></Reference><Reference><Citation>Varrone A., Asenbaum S., Vander Borght T. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36(12):2103&#x2013;2110. doi: 10.1007/s00259-009-1264-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-009-1264-0</ArticleId><ArticleId IdType="pubmed">19838705</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbelli S., Perneczky R., Drzezga A. Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project. J Nucl Med Off Publ Soc Nucl Med. 2013;54(6):894&#x2013;902. doi: 10.2967/jnumed.112.113928.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.112.113928</ArticleId><ArticleId IdType="pubmed">23591639</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A., Iazzolino B., Calvo A. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry. 2015;86(2):168&#x2013;173. doi: 10.1136/jnnp-2013-307223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307223</ArticleId><ArticleId IdType="pubmed">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J., Grace G.M., Freedman M. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Off Publ World Fed Neurol Res Group Mot Neuron Dis. 2009;10(3):131&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">19462523</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;hulst L, Van Weehaeghe D, Chi&#xf2; A, et al. Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls. Amyotroph Lateral Scler Front Degener. 2018;19(7-8):570-577. doi:10.1080/21678421.2018.1476548.</Citation><ArticleIdList><ArticleId IdType="pubmed">29862846</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A., Pagani M., Cistaro A. 18F-FDG-PET correlates of cognitive impairment in ALS. Neurology. 2016;86(1):44&#x2013;49. doi: 10.1212/WNL.0000000000002242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002242</ArticleId><ArticleId IdType="pubmed">26590270</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Pagani M., Agosta F., Calvo A., Cistaro A., Filippi M. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol. 2014;13(12):1228&#x2013;1240. doi: 10.1016/S1474-4422(14)70167-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70167-X</ArticleId><ArticleId IdType="pubmed">25453462</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagani M., Chi&#xf2; A., Valentini M.C. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology. 2014;83(12):1067&#x2013;1074. doi: 10.1212/WNL.0000000000000792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000792</ArticleId><ArticleId IdType="pubmed">25122207</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Laere K., Vanhee A., Verschueren J. Value of 18fluorodeoxyglucose-positron- emission tomography in amyotrophic lateral sclerosis: a prospective study. JAMA Neurol. 2014;71(5):553&#x2013;561. doi: 10.1001/jamaneurol.2014.62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.62</ArticleId><ArticleId IdType="pubmed">24615479</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeber S.L., Otis T.S., Sillitoe R.V. New roles for the cerebellum in health and disease. Front Syst Neurosci. 2013;7:83. doi: 10.3389/fnsys.2013.00083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsys.2013.00083</ArticleId><ArticleId IdType="pmc">PMC3827539</ArticleId><ArticleId IdType="pubmed">24294192</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke R a. L, Proudfoot M, Talbot K, Turner MR. The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis. NeuroImage Clin. 2018;17:953-961. doi:10.1016/j.nicl.2017.12.025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5752097</ArticleId><ArticleId IdType="pubmed">29321969</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu T., Zhang Y., Tang X. Precentral degeneration and cerebellar compensation in amyotrophic lateral sclerosis: A multimodal MRI analysis. Hum Brain Mapp. 2019;40(12):3464&#x2013;3474. doi: 10.1002/hbm.24609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.24609</ArticleId><ArticleId IdType="pmc">PMC6865414</ArticleId><ArticleId IdType="pubmed">31020731</ArticleId></ArticleIdList></Reference><Reference><Citation>Abidi M., de Marco G., Couillandre A. Adaptive functional reorganization in amyotrophic lateral sclerosis: coexisting degenerative and compensatory changes. Eur J Neurol. 2020;27(1):121&#x2013;128. doi: 10.1111/ene.14042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14042</ArticleId><ArticleId IdType="pubmed">31310452</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum J.M., Stambler N. Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. J Neurol Sci. 1997;152(Suppl 1):S1&#x2013;S9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9419047</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Wotton C., Talbot K., Goldacre M.J. Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry. 2012;83(4):395&#x2013;398. doi: 10.1136/jnnp-2011-301161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301161</ArticleId><ArticleId IdType="pubmed">22072701</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson P., L&#xf6;nnstedt I., Nygren I., Askmark H. Physical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early age. J Neurol Neurosurg Psychiatry. 2012;83(4):390&#x2013;394. doi: 10.1136/jnnp.2010.218982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.218982</ArticleId><ArticleId IdType="pubmed">20852312</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman M.H.B., Seelen M., de Jong S.W. Lifetime physical activity and the risk of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84(9):976&#x2013;981. doi: 10.1136/jnnp-2012-304724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304724</ArticleId><ArticleId IdType="pubmed">23418211</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Mora G. Physical fitness and amyotrophic lateral sclerosis: dangerous liaisons or common genetic pathways? J Neurol Neurosurg Psychiatry. 2012;83(4):389. doi: 10.1136/jnnp-2012-302351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-302351</ArticleId><ArticleId IdType="pubmed">22399797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamidou B., Couratier P., Besan&#xe7;on C., Nicol M., Preux P.M., Marin B. Epidemiological evidence that physical activity is not a risk factor for ALS. Eur J Epidemiol. 2014;29(7):459&#x2013;475. doi: 10.1007/s10654-014-9923-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-014-9923-2</ArticleId><ArticleId IdType="pubmed">24986107</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C.R., Knopman D.S., Weigand S.D. An operational approach to National Institute on Aging-Alzheimer&#x2019;s Association criteria for preclinical Alzheimer disease. Ann Neurol. 2012;71(6):765&#x2013;775. doi: 10.1002/ana.22628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22628</ArticleId><ArticleId IdType="pmc">PMC3586223</ArticleId><ArticleId IdType="pubmed">22488240</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F., H&#xe5;llmarker U., James S. Amyotrophic lateral sclerosis among cross-country skiers in Sweden. Eur J Epidemiol. 2016;31(3):247&#x2013;253. doi: 10.1007/s10654-015-0077-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-015-0077-7</ArticleId><ArticleId IdType="pubmed">26220522</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S, Noyce AJ, Hemani G, et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol. Published online February 5, 2019. doi:10.1002/ana.25431</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes J., Arida R.M., Gomez-Pinilla F. Physical exercise as an epigenetic modulator of brain plasticity and cognition. Neurosci Biobehav Rev. 2017;80:443&#x2013;456. doi: 10.1016/j.neubiorev.2017.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2017.06.012</ArticleId><ArticleId IdType="pmc">PMC5705447</ArticleId><ArticleId IdType="pubmed">28666827</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Legault J., Litcofsky K.A. Neuroplasticity as a function of second language learning: anatomical changes in the human brain. Cortex J Devoted Study Nerv Syst Behav. 2014;58:301&#x2013;324. doi: 10.1016/j.cortex.2014.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2014.05.001</ArticleId><ArticleId IdType="pubmed">24996640</ArticleId></ArticleIdList></Reference><Reference><Citation>Todorova V., Blokland A. Mitochondria and Synaptic Plasticity in the Mature and Aging Nervous System. Curr Neuropharmacol. 2017;15(1):166&#x2013;173. doi: 10.2174/1570159x14666160414111821.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159x14666160414111821</ArticleId><ArticleId IdType="pmc">PMC5327446</ArticleId><ArticleId IdType="pubmed">27075203</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>